Patent · US Active

Formulation containing anti-inflammatory androstane derivative

US7541350B2 · kind B2 · utility

5Cited by
56References
7Claims
0Family size

Assignee

Inventors

Key dates

Filing dateAug 13, 2004
Grant dateJun 2, 2009
Priority date—
Expiry dateFeb 3, 2027

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61K47/38
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

There is provided a pharmaceutical formulation comprising an aqueous suspension of particulate compound of formula (I)or a solvate thereof.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.